iRhythm Technologies (NASDAQ: IRTC) reported Q4 EPS of ($0.84), $0.25 worse than the analyst estimate of ($0.59). Revenue for the quarter came in at $132.5 million versus the consensus estimate of $129.87 million.

GUIDANCE:

iRhythm Technologies sees FY2024 revenue of $575-585 million, versus the consensus of $581 million. Gross margin for the full year 2024 is expected to range from 68% to 69% and adjusted EBITDA margin for the full year 2024 is expected to range from approximately 3% to 4% of revenues.

For earnings history and earnings-related data on iRhythm Technologies (IRTC) click here.